Ildar Gabaev

Title: Ildar Gabaev: Innovator in Immune Suppression

Introduction

Ildar Gabaev is a notable inventor based in Hanover, Germany. He has made significant contributions to the field of immunology through his innovative research and development of new therapeutic agents. His work focuses on the interaction between viral proteins and the immune system, which has important implications for medical treatments.

Latest Patents

Ildar Gabaev holds a patent for an invention titled "Immune Suppressor and Its Use." This patent describes a new binder molecule that serves as an immune suppressor. The invention highlights the UL11 protein of human cytomegalovirus, which binds to the CD45 molecule, potentially altering an individual's immune system. The patent also discusses binder molecules, particularly fusion molecules that contain the CD45 binding domain of the UL11 protein, aimed at delivering therapeutic agents to cells expressing the CD45 molecule. Additionally, it covers pharmaceutical compositions that include the UL11 protein or its derivatives.

Career Highlights

Ildar Gabaev is affiliated with the Medizinische Hochschule Hannover, where he conducts his research. His work has led to advancements in understanding immune responses and developing new therapeutic strategies. With a focus on innovative solutions, he continues to contribute to the scientific community.

Collaborations

Ildar has collaborated with notable colleagues, including Thomas Schulz and Penelope Kay-Fedorov. These collaborations have enriched his research and expanded the impact of his inventions in the field of immunology.

Conclusion

Ildar Gabaev is a pioneering inventor whose work on immune suppression has the potential to transform therapeutic approaches in medicine. His innovative patent and collaborations reflect his commitment to advancing scientific knowledge and improving health outcomes.